Dr. Alison Fox-Robichaud is Professor of Medicine at McMaster University and an Intensivist and Director of Medical Education at Hamilton Health Sciences. She received an Honours BSc from Biology and Chemistry from the University of New Brunswick and her MSc in Medical Sciences at McMaster University. She completed her MD at the University of Ottawa followed by Internal Medicine, Critical Care and Postdoctoral training at the University of Calgary. She returned to McMaster as faculty in 2000. Her research interests include the pathophysiology of sepsis and how evidence is transferred into clinical care. She holds CHRP funding for the development of a point of care device for the detection of cell free DNA. She is the Scientific Director of the recently CHIR-funded Canadian Sepsis Research Network; Sepsis Canada is research collaborative of 190 scientists, knowledge users and patients and family partners.
Past president of the Canadian Critical Care Society and inaugural president of the Canadian Sepsis Foundation, her more than 95 peer-reviewed publications reflect a broad engagement in academic medicine. She is an executive member of the Canadian Critical Care Translational Biology Group and members of the board of the Canadian Critical Care Trials Group and the Global Sepsis Alliance. In 2015, she received a Leading Practice Award from Accreditation Canada for the integration of an electronic early warning score into the medical record. In 2018, the Global Sepsis Alliance awarded her an individual award for her sepsis leadership